For example, ECM protein fibronectin could activate Wnt/β-catenin pathway to induce the stem cell phenotype in cancer cells by binding membrane receptor integrin β1, while a disruption of this interaction could inhibit CSC self-renewal and tumor-initiating capacity [50]. The gene discussed is FN1; the disease is cancer.